This compound, known as Tenofovir alafenamide, is a prodrug primarily utilized in medicinal chemistry for antiviral therapies. It enhances the delivery and bioavailability of the nucleoside analog tenofovir, which is essential for treating HIV-1 infection and chronic hepatitis B. The chemical structure facilitates improved cellular uptake and targeted intracellular release of the active antiviral agent, leading to higher efficacy and reduced systemic side effects compared to earlier formulations. Its applications are focused on managing these viral diseases, with ongoing research exploring broader antiviral potentials.